Mutagen sensitivity has high heritability: Evidence from a twin study

Cancer Research

Volumn 66, Issue 12, 2006, Pages 5993-5996

  Wu, Xifeng ^a   Spitz, Margaret R ^a   Amos, Christopher I ^a   Lin, Jie ^a   Shao, Lina ^a   Gu, Jian ^a   De Andrade, Mariza ^b   Benowitz, Neal L ^c   Shields, Peter G ^d   Swan, Gary E ^e  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

^e SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BENZO(A)PYRENE DIOL EPOXIDE; BENZO[A]PYRENE; BLEOMYCIN; MUTAGENIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOMETRY; CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; GAMMA RADIATION; GENETIC MODEL; HEREDITY; HERITABILITY; HUMAN; HUMAN EXPERIMENT; MONOZYGOTIC TWINS; MUTAGEN TESTING; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TWINS;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; MUTAGENICITY TESTS; MUTAGENS; NEOPLASMS; TWINS;

EID: 33745728456     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1007     Document Type: Article

References (24)

1. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-97.
2. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 2003;12:689-98.
3. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43:403-9.
4. Wu X, Hsu TC, Spitz MR. Mutagen sensitivity exhibits a dose-response relationship in case-control studies. Cancer Epidemiol Biomarkers Prev 1996;5:577-8.
5. Wu X, Gu J, Amos CI, Jiang H, Hong WK, Spitz MR. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung cancer cases and controls. Cancer 1998;83:1118-27.
6. Gu J, Bondy ML, Sigurdson A, Spitz MR, Hsu TC, Wu X. Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet 1999;110:65-9.
7. Buchholz TA, Wu X. Radiation-induced chromatid breaks as a predictor of breast cancer risk. Int J Radiat Oncol Biol Phys 2001;49:533-7.
8. Bondy ML, Kyritsis A, Gu J, et al. Mutagen sensitivity and risk of gliomas: a case-control analysis. Cancer Res 1996;56:1484-6.
9. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. Genetics of risk factors for melanoma: an adult twin study of nevi and freckles. J Natl Cancer Inst 2000;92:457-63.
10. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
11. Swan GE, Benowitz NL, Jacob P III, et al. Pharmacogenetics of nicotine metabolism in twins: methods and procedures. Twin Res 2004;7:435-48.
12. Swan GE, Benowitz NL, Lessov CN, Jacob P, Tyndale RF, Wilhelmsen K. Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenomics 2005;15:115-25.
13. Amos CI, Zhu DK, Boerwinkle E. Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet 1996;60:143-60.
14. de Andrade M, Amos CI, Thiel TJ. Methods to estimate genetic components of variance for quantitative traits in family studies. Genet Epidemiol 1999;17:64-76.
15. Cloos J, Steen I, Joenje H, et al. Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer. Cancer Lett 1993;74:161-5.
16. King TM, Trizna Z, Wu X, et al. A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. Cancer Epidemiol Biomarkers Prev 1997;6:537-42.
17. Knight RB, Parshad R, Price FM, Tarone RE, Sanford KK. X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int J Cancer 1993;54:589-93.
18. Roberts SA, Spreadborough AR, Bulman B, Barber JBP, Evans DGR, Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer. Am J Hum Genet 1999;65:784-94.
19. Scott D. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 2004;104:365-70.
20. Cloos J, Spitz MR, Schantz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:530-4.
21. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet 2002;3:872-82.
22. Cloos J, Nieuwenhuis EJ, Boomsma DI, et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst 1999;91:1125-30.
23. Tedeschi B, Cicchetti R, Argentin G, et al. Aphidicolin and bleomycin induced chromosome damage as biomarker of mutagen sensitivity: a twin study. Mutat Res 2004;546:55-64.
24. Pastwa E, Neumann RD, Mezhevaya K, Winters TA. Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiat Res 2003;159:251-61.